Carpmaels & Ransford LLP > London, England > Firm Profile

Carpmaels & Ransford LLP > The Legal 500 Rankings

TMT (technology, media and telecoms) > PATMA: Patent attorneys Tier 1

Carpmaels & Ransford LLP is notable for its expertise in supporting healthcare clients, including those from the pharmaceutical, chemical, and biotechnology industries. It is praised by clients for its ability to handle the entire spectrum of patent-related mandates, including ‘patent prosecution, strategy, post-grant proceedings, and litigation’, as well as EPO opposition work. The practice is also able to utilise the firm’s strong dispute resolution offering to assist in litigation matters. Managing partner and pan-European prosecution expert Hugh Goodfellow leads the life sciences group and is highly experienced in handling oppositions and appeals before the EPO, while John Brunner heads up the engineering and technology teams, assisting clients with their medical devises involving software, AI, and electronics. James Warner spearheads the chemistry and pharmaceuticals group, which advises clients in the consumer, nutraceuticals, and the medical device spaces, while Mark Chapman chairs the biotechnology team.

TMT (technology, media and telecoms) > PATMA: Trade mark attorneys Tier 2

Carpmaels & Ransford LLP’s practice encompasses the entire life cycle trade marks, from clearance searches, registrations, and enforcement, to disputes, litigation, licensing, and contractual and transactional matters, and it often represents clients in opposition and appeal proceedings before the UKIPO, EPO, WIPO, and the UK’s Appointed Person. Roger Lush chairs the group and his clients are from a wide range of sectors, including healthcare and pharmaceuticals, media and entertainment, tourism, and fintech and finance, amongst others. Dual qualified as a trade mark attorney and solicitor, Jonathan Day, is strong on brand protection, enforcement mandates, and management matters. Senior associate and trade mark attorney Lara Elder is skilled in both contentious and non-contentious matters.

TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious) Tier 3

Covering the full spectrum of IP rights, Carpmaels & Ransford LLP’s ‘highly intelligent’ and ‘collaborative’ team is particularly noted for its expertise in advising healthcare innovators on EPO opposition defence and strategic prosecution. Heading the dispute resolution team is David Wilson, who is well-versed in the pharma and telecoms sectors, while Jake Marshall, who leads the IP transactions team, possesses numerous capabilities, from handling IP licensing deals to complex IP-heavy commercial arrangements. Ian Kirby has considerable experience in technology-related litigation. Camilla Balleny focuses on multi-jurisdictional patent litigation and life sciences-related advisory work. Jennifer Antcliff has successfully represented clients in leading life sciences cases in all courts up to, and including, the Supreme Court.

Industry focus > Life sciences and healthcare Tier 4

Praised for exhibiting ‘deep industry knowledge‘, Carpmaels & Ransford LLP is noted for assisting clients with trade marks, data protection, and orphan exclusivities. David Wilson has a great deal of experience in handling patent disputes concerning license agreements, and the ‘very talented and extremely dedicated‘ Jennifer Antcliff regularly appears before the Court of Appeal, Supreme Court, and the CJEU in SPC cases. Jake Marshall primarily focuses on transactional IP matters, and Hugh Goodfellow is particularly adept at the filing and prosecution of SPCs, and oppositions. James Warner leads on the chemical and pharmaceutical side, frequently handling EPO opposition proceedings. Mark Chapman heads up the biotech team, and has vast experience in pre and post-grant proceedings before the EPO.